We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Japan: PMDA Notice Shows Increasing Willingness to Accept Global Clinical Trials
Japan: PMDA Notice Shows Increasing Willingness to Accept Global Clinical Trials
October 8, 2012
Japan’s Pharmaceutical and Medical Devices Agency (PMDA) cited increasing regulatory cooperation with China and South Korea in saying it will now accept new drug applications that rely on well-designed, well-conducted global clinical trials in the neighboring East Asian nations. Includes the full text of Japan’s Basic Principles on Foreign Clinical Trials.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor